Last edition
News about "Weimin Wang"
SanegeneBio Announces RNAi Global Licensing Collaboration with Genentech
SanegeneBio has licensed one of its RNAi programmes to Genentech in a global collaboration valued at up to USD 1.7 billion, including a USD 200 million upfront payment, milestone-based development and commercialisation payments, and tiered royalties. Genentech will oversee worldwide clinical development and commercialisation.
Weimin Wang | 03/02/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members